A detailed history of Amalgamated Bank transactions in Bioventus Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,299 shares of BVS stock, worth $13,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,299
Previous 1,299 -0.0%
Holding current value
$13,028
Previous $7,000 128.57%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$3.96 - $6.93 $5,144 - $9,002
1,299 New
1,299 $7,000
Q1 2023

May 02, 2023

SELL
$1.07 - $2.95 $762 - $2,103
-713 Reduced 18.53%
3,134 $3,000
Q2 2022

Aug 15, 2022

SELL
$6.82 - $13.82 $2,768 - $5,610
-406 Reduced 9.55%
3,847 $26,000
Q1 2022

Jun 30, 2022

BUY
$11.65 - $15.28 $49,547 - $64,985
4,253 New
4,253 $60,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $618M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.